ZBH

#614
Zimmer Biomet Holdings, Inc. Common Stock
82.3 4 USD
-0.70%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
82.26
82.83
Range Annuel
0.83
103.69
Changement quotidien
-0.70%
Changement Mensuel
+1.90%
Evolution sur 6 mois
-15.30%
Changement Annuel
-20.44%
Clôture Précédente
82.9 2
Open
82.7 4
Low
82.2 6
High
82.8 3
Volume
1 126
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 15.93 B
  • Employee 17 K
  • Founded N/A
  • CEO Ivan Tornos
  • Website www.zimmerbiomet.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKPL53
  • Industry Dispositifs Médicaux
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
25.33
ratio cours/chiffre d'affaires
2.25
Dividende par action
0.96
Rendement du dividende (%)
1.07

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.

Nouvelles